The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a shared-care model between community and academic centers for facilitating access to allogeneic and autologous stem cell transplantation.
 
Joshua Alexander Fein
No Relationships to Disclose
 
Agnes McAuliffe
No Relationships to Disclose
 
Kimberly Fischer
No Relationships to Disclose
 
Owen Brady
No Relationships to Disclose
 
Sean M. Devlin
No Relationships to Disclose
 
Silvia Willumsen
No Relationships to Disclose
 
Gonca Ozcan
No Relationships to Disclose
 
Pat Montanaro
No Relationships to Disclose
 
Yelena Pristyazhnyuk
No Relationships to Disclose
 
Joseph Digiuseppe
No Relationships to Disclose
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune
Honoraria - MorphoSys
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Cidara Therapeutics; Incyte; Kite/Gilead; Medigene; Merck; MolMed; Nektar; NexImmune; Novartis; Omeros; Servier/Pfizer; Vor Biopharma
Research Funding - Incyte (Inst); Kite, a Gilead company (Inst); Miltenyi Biotec (Inst); Nektar (Inst); Novartis (Inst)
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Incyte
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Hookipa Pharma (Inst); Lilly (Inst); MedImmune (Inst); MeiraGTx (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Sergio Giralt
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Pfizer; Sanofi
 
Mark Dailey
No Relationships to Disclose
 
Peter Paul Yu
Stock and Other Ownership Interests - Amazon; Apple; Contrafect; Danaher; Google; Microsoft
 
Craig Steven Sauter
Consulting or Advisory Role - Gamida Cell; Genmab; Gilead Sciences; GlaxoSmithKline; Juno Therapeutics; Karyopharm Therapeutics; Novartis; Precision Biosciences; Sanofi; Spectrum Pharmaceuticals
Research Funding - Actinium Pharmaceuticals (Inst); BMS (Inst); Juno Therapeutics; Precision Biosciences (Inst); Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Juno Therapeutics; Novartis; Sanofi